Provided by Tiger Trade Technology Pte. Ltd.

Lantheus

80.45
+1.952.48%
Post-market: 80.20-0.2500-0.31%18:20 EDT
Volume:833.98K
Turnover:66.43M
Market Cap:5.20B
PE:23.59
High:80.46
Open:78.76
Low:78.23
Close:78.50
52wk High:108.91
52wk Low:47.25
Shares:64.61M
Float Shares:59.94M
Volume Ratio:0.66
T/O Rate:1.39%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.41
EPS(LYR):3.41
ROE:21.45%
ROA:9.27%
PB:4.77
PE(LYR):23.59

Loading ...

Analysts Are Bullish on Top Healthcare Stocks: Lantheus (LNTH), Perspective Therapeutics (CATX)

TIPRANKS
·
7 hours ago

BRIEF-Lantheus Announces Three-Month Extension Of PDUFA Date For LNTH-2501

Reuters
·
8 hours ago

Lantheus announces three-month extension of LNTH-2501 PDUFA date

TIPRANKS
·
8 hours ago

US FDA extends review of Lantheus' diagnostic imaging kit by three months

Reuters
·
8 hours ago

Lantheus Holdings Inc - FDA Extends Review of Lnth-2501 Nda to June 29, 2026

THOMSON REUTERS
·
8 hours ago

Lantheus Announces Three-Month Extension of Pdufa Date for Lnth-2501 (Ga 68 Edotreotide), a Pet Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (Sstr+) Neuroendocrine Tumors (Nets)

THOMSON REUTERS
·
8 hours ago

Lantheus Announces Three-Month Extension of PDUFA Date for LNTH-2501 (Ga 68 edotreotide), a PET Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (SSTR+) Neuroendocrine Tumors (NETs)

GlobeNewswire
·
8 hours ago

Lantheus price target raised to $110 from $105 at Jefferies

TIPRANKS
·
9 hours ago

Lantheus Holdings Up Over 9%, on Pace for Largest Percent Increase Since February 2025 -- Data Talk

Dow Jones
·
Mar 10

Analysts’ Top Healthcare Picks: IDEAYA Biosciences (IDYA), Lantheus (LNTH)

TIPRANKS
·
Mar 09

Analysts Are Bullish on Top Healthcare Stocks: Dianthus Therapeutics (DNTH), Lantheus (LNTH)

TIPRANKS
·
Mar 09

Korn Ferry, Hewlett Packard Enterprise And 3 Stocks To Watch Heading Into Monday

Benzinga
·
Mar 09

US FDA approves Lantheus’ new prostate cancer imaging formulation

Reuters
·
Mar 07

Lantheus Holdings Inc - Pylarify Truvu Expected to Launch in Q4 2026 With Phased Rollout

THOMSON REUTERS
·
Mar 07

Lantheus Announces FDA Approval of Pylarify Truvu™ (Piflufolastat F 18) Injection

THOMSON REUTERS
·
Mar 07

Lantheus Announces FDA Approval of PYLARIFY TruVu™ (piflufolastat F 18) Injection

GlobeNewswire
·
Mar 07

Stock Track | Lantheus Soars 5.07% Intraday on FDA Tentative Approval and Analyst Price Target Hike

Stock Track
·
Mar 02

Lantheus Says US FDA Tentatively Approves PNT2003

MT Newswires Live
·
Mar 02

Lantheus Holdings Is Maintained at Buy by Truist Securities

Dow Jones
·
Mar 02

Lantheus receives U.S. FDA tentative approval for Lutetium Lu 177

TIPRANKS
·
Mar 02